This is obviously the US, and migraineurs in the UK may have to wait a while, but it’s nevertheless promising that the FDA have approved a new drug for the treatment of migraine:

The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Ubrelvy is not indicated for the preventive treatment of migraine. It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.

I’m currently using Rizatriptan to relieve migraines, which produces the desired result (i.e. gets rid of aura), but comes with side effects.